These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 29532536)
1. Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patients. Martin AC; Lessire S; Leblanc I; Dincq AS; Philip I; Gouin-Thibault I; Godier A Clin Cardiol; 2018 May; 41(5):646-651. PubMed ID: 29532536 [TBL] [Abstract][Full Text] [Related]
2. Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation: Understanding the Gaps in Evidence. Martin AC; Godier A; Narayanan K; Smadja DM; Marijon E Circulation; 2018 Aug; 138(6):627-633. PubMed ID: 30354610 [TBL] [Abstract][Full Text] [Related]
3. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes. Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2823-2833. PubMed ID: 31701593 [TBL] [Abstract][Full Text] [Related]
4. Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment. Zhang RF; Ma CM; Wang N; Yang MH; Li WW; Yin XM; Dong YX; Yu XH; Xiao XJ; Xia YL; Gao LJ BMC Cardiovasc Disord; 2021 Apr; 21(1):214. PubMed ID: 33906609 [TBL] [Abstract][Full Text] [Related]
5. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants. Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158 [TBL] [Abstract][Full Text] [Related]
6. Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial. Hohnloser SH; Camm AJ; Cappato R; Diener HC; Heidbüchel H; Mont L; Morillo CA; Lanz HJ; Rauer H; Reimitz PE; Smolnik R; Kautzner J Europace; 2021 Jan; 23(1):65-72. PubMed ID: 33249467 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation of Atrial Fibrillation in the Presence of Direct Oral Anticoagulants and Wide Spectrum of Body Mass Index. Safani M; Tobias S; Shandling AH; Redmond K; Lee MY J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):349-358. PubMed ID: 33749350 [TBL] [Abstract][Full Text] [Related]
9. Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin. Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S J Cardiovasc Electrophysiol; 2018 Jun; 29(6):835-843. PubMed ID: 29533476 [TBL] [Abstract][Full Text] [Related]
10. Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter? Martin AC; Kyheng M; Foissaud V; Duhamel A; Marijon E; Susen S; Godier A J Clin Med; 2020 Jan; 9(2):. PubMed ID: 32012701 [TBL] [Abstract][Full Text] [Related]
11. Catheter ablation of left atrial arrhythmias on uninterrupted oral anticoagulation with vitamin K antagonists: What is the relationship between international normalized ratio, activated clotting time, and procedure-related complications? Kottmaier M; Bourier F; Semmler V; Telishevska M; Koch-Büttner K; Lennerz C; Lengauer S; Kornmayer M; Rousseva E; Brooks S; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I; Reents T J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1415-1422. PubMed ID: 28800176 [TBL] [Abstract][Full Text] [Related]
12. Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures. Benali K; Verain J; Hammache N; Guenancia C; Hooks D; Magnin-Poull I; Toussaint-Hacquard M; de Chillou C; Sellal JM J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575348 [TBL] [Abstract][Full Text] [Related]
13. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study. Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464 [TBL] [Abstract][Full Text] [Related]
14. Protocol driven periprocedural anticoagulation for left atrial ablation. Bradley CJ; Williamson BD; George J; Haines DE J Cardiovasc Electrophysiol; 2021 Mar; 32(3):639-646. PubMed ID: 33476459 [TBL] [Abstract][Full Text] [Related]
15. Periprocedural Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation Without Discontinuation of a Vitamin K Antagonist and Direct Oral Anticoagulants. Kojima T; Fujiu K; Fukuma N; Matsunaga H; Oshima T; Matsuda J; Matsubara T; Shimizu Y; Oguri G; Hasumi E; Morita H; Komuro I Circ J; 2018 May; 82(6):1552-1557. PubMed ID: 29657252 [TBL] [Abstract][Full Text] [Related]
16. Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis. Ha FJ; Barra S; Brown AJ; Begley DA; Grace AA; Agarwal S Int J Cardiol; 2018 Jul; 262():51-56. PubMed ID: 29606512 [TBL] [Abstract][Full Text] [Related]
17. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation. Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944 [TBL] [Abstract][Full Text] [Related]
18. Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials. Brockmeyer M; Lin Y; Parco C; Karathanos A; Krieger T; Schulze V; Heinen Y; Bejinariu A; Müller P; Makimoto H; Kelm M; Wolff G Acta Cardiol; 2021 May; 76(3):288-295. PubMed ID: 32056498 [TBL] [Abstract][Full Text] [Related]
19. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation. Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495 [TBL] [Abstract][Full Text] [Related]
20. Clinical Impact of Heparin Kinetics During Catheter Ablation of Atrial Fibrillation: Meta-Analysis and Meta-Regression. Briceno DF; Villablanca PA; Lupercio F; Kargoli F; Jagannath A; Londono A; Patel J; Otusanya O; Brevik J; Maraboto C; Berardi C; Krumerman A; Palma E; Kim SG; Natale A; DI Biase L J Cardiovasc Electrophysiol; 2016 Jun; 27(6):683-93. PubMed ID: 27004444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]